Herspiegel Consulting Acquires Adivo Associates

Herspiegel Acquires U.K.-based Decisive Consulting

June 23, 2025

Healthcare Services

Herspiegel, a pharmaceutical commercialization consultancy and portfolio company of DFW Capital Partners, has acquired U.K.-based Decisive Consulting to expand its global market access, HEOR and HTA capabilities. Decisive's founder Esther Nzenza will remain in a senior role as the firm is integrated into Herspiegel's global commercialization platform.

Herspiegel Acquires FIECON

April 7, 2025

Healthcare Services

Herspiegel has integrated FIECON, a leading European health economics and market access consultancy, bringing a team of over 250 employees and a London office into Herspiegel’s global commercialization platform. The transaction strengthens Herspiegel’s market access, HTA, and RWE capabilities and expands its European presence to better support pharmaceutical, biotech, and medical device clients across reimbursement and commercialization strategies.

DFW Capital Partners Makes Growth Investment in Herspiegel Consulting

December 14, 2021

Healthcare Services

DFW Capital Partners completed a growth investment in Herspiegel Consulting, a Yardley, Pennsylvania–based provider of commercial strategy and implementation consulting for the pharmaceutical and biotechnology industries. The partnership will support Herspiegel's growth and expansion of its commercial capabilities and reach.

Sheridan Capital Partners Invests in ADVI Health

December 1, 2022

Healthcare Services

Sheridan Capital Partners has taken an ownership stake in ADVI Health, investing alongside ADVI senior leaders who retained a meaningful ownership interest and will remain active in leadership. The investment is intended to accelerate ADVI's growth by expanding its market-access, commercialization, and policy offerings and scaling its data-informed products and services.

ADVI Health Acquires Partnership for Health Analytic Research (PHAR)

August 23, 2024

Healthcare Services

ADVI Health has acquired Partnership for Health Analytic Research (PHAR), a global HTA and HEOR consultancy with roughly 20 years of experience delivering real-world evidence, patient registries, and value strategy research for biopharma clients. The acquisition expands ADVI’s Strategic Analytics, Value and Economics (SAVEs) capabilities—bringing PHAR’s HEOR and implementation science expertise into ADVI’s market access and commercialization services.

Danforth Advisors Acquires Advyzom

September 10, 2024

Healthcare Services

Danforth Advisors has acquired Advyzom, a New Jersey–based regulatory affairs consultancy of approximately 30 specialists, expanding Danforth's clinical and regulatory capabilities to offer a comprehensive suite of services for life science companies. The acquisition integrates Advyzom's regulatory strategy, FDA liaison, medical writing, and submissions expertise into Danforth's platform to better support clients across development, approval, and market entry.